• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一项关于新生儿呼吸窘迫综合征管理的全国性调查:来自中国 394 家医院的慕尼黑调查的见解。

A nationwide survey on the management of neonatal respiratory distress syndrome: insights from the MUNICH survey in 394 Chinese hospitals.

机构信息

Department of Neonatology, Women and Children's Hospital of Chongqing Medical University, Chongqing Health Center for Women and Children, No.120 Longshan Road, Yubei District, Chongqing, China.

Department of Neonatology, Children's Hospital of Shanxi, No.310 Changzhi Road, Xiaodian District, Taiyuan, Shanxi, China.

出版信息

Ital J Pediatr. 2024 Sep 7;50(1):168. doi: 10.1186/s13052-024-01741-7.

DOI:10.1186/s13052-024-01741-7
PMID:39244592
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11380405/
Abstract

BACKGROUND

At present, preterm infants with respiratory distress syndrome (RDS) in China present higher mortality and morbidity rates than those in high-income countries. The aim of this nationwide survey was to assess the clinical management of RDS in China.

METHODS

A nationwide cross-sectional survey to assess adherence to RDS management recommendations was performed. One neonatologist per hospital was randomly selected. The primary outcome was the key care of RDS management.

RESULTS

Among the 394 participating hospitals, 88·3% were birthing centres. The number of doctors and nurses per bed were 0·27 and 0·72, respectively. Antenatal corticosteroids (any dose) were administered to 90% of the women at risk of preterm birth at < 34 weeks of gestation (90·0% inborn vs. 50·0% outborn, p < 0·001). The median fraction of inspired oxygen (FiO) for initial resuscitation was 0·30 for babies born at ≤ 32 weeks of gestation and 0·25 for those born at > 32 weeks. T-piece resuscitators were available in 77·8% of delivery rooms (DRs) (tertiary hospitals: 82·5% vs. secondary hospitals: 63·0%, p < 0·001). Surfactant was used in 51·6% of the DRs. Less invasive surfactant administration (LISA) was used in 49·7% of the hospitals (tertiary hospitals: 55·3% vs. secondary hospitals: 31·5%, p < 0·001). Primary non-invasive ventilation was initiated in approximately 80·0% of the patients. High-frequency oscillation ventilation was primarily reserved for rescue after conventional mechanical ventilation (MV) failure. Caffeine was routinely used during MV in 59·1% of the hospitals. Bedside lung ultrasonography was performed in 54·3% of the health facilities (tertiary hospitals: 61·6% vs. secondary hospitals: 30·4%, p < 0·001). Qualified breast milk banks and Family Integrated Care (FICare) were present in 30·2% and 63·7% of the hospitals, respectively.

CONCLUSIONS

Significant disparities in resource availability and guidelines adherence were evident across hospitals. Future strategies should address DR facilities and medication access, technical training, staff allocation, and ancillary facility development for a better management of RDS patients in China.

摘要

背景

目前,中国患有呼吸窘迫综合征(RDS)的早产儿死亡率和发病率高于高收入国家。本项全国性调查旨在评估中国 RDS 的临床管理情况。

方法

开展了一项全国性的横断面调查,以评估 RDS 管理建议的实施情况。每家医院随机选择一名新生儿科医生。主要结局为 RDS 管理的关键护理。

结果

在参与的 394 家医院中,88.3%为分娩中心。每床医生和护士人数分别为 0.27 和 0.72。90.0%的有早产风险的孕妇(<34 孕周)接受了产前皮质激素(任何剂量)治疗(院内分娩:90.0%;院外分娩:50.0%,p<0.001)。胎龄≤32 周出生的婴儿初始复苏时吸入氧分数中位数为 0.30,胎龄>32 周出生的婴儿为 0.25。复苏 T 型管在 77.8%的产房(三级医院:82.5%;二级医院:63.0%,p<0.001)中可用。51.6%的产房使用了肺表面活性物质。49.7%的医院采用了经鼻间歇正压通气(初级无创通气)(三级医院:55.3%;二级医院:31.5%,p<0.001)。大约 80.0%的患者开始使用高频振荡通气。高频振荡通气主要作为常规机械通气(MV)失败后的抢救措施。59.1%的医院在 MV 期间常规使用咖啡因。54.3%的医疗机构(三级医院:61.6%;二级医院:30.4%,p<0.001)开展了床边肺部超声检查。合格的母乳库和家庭综合护理(FICare)分别存在于 30.2%和 63.7%的医院。

结论

不同医院在资源可用性和指南依从性方面存在显著差异。未来的策略应解决产房设施和药物获取、技术培训、人员配置以及辅助设施的发展,以更好地管理中国的 RDS 患者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e10d/11380405/72841c7cf92e/13052_2024_1741_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e10d/11380405/3022d672777d/13052_2024_1741_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e10d/11380405/698200ef4121/13052_2024_1741_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e10d/11380405/72841c7cf92e/13052_2024_1741_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e10d/11380405/3022d672777d/13052_2024_1741_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e10d/11380405/698200ef4121/13052_2024_1741_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e10d/11380405/72841c7cf92e/13052_2024_1741_Fig3_HTML.jpg

相似文献

1
A nationwide survey on the management of neonatal respiratory distress syndrome: insights from the MUNICH survey in 394 Chinese hospitals.一项关于新生儿呼吸窘迫综合征管理的全国性调查:来自中国 394 家医院的慕尼黑调查的见解。
Ital J Pediatr. 2024 Sep 7;50(1):168. doi: 10.1186/s13052-024-01741-7.
2
Less invasive surfactant administration versus endotracheal surfactant instillation followed by limited peak pressure ventilation in preterm infants with respiratory distress syndrome in China: study protocol for a randomized controlled trial.经鼻给予肺表面活性物质与气管内给予肺表面活性物质后行小潮气量通气治疗中国呼吸窘迫综合征早产儿的随机对照试验研究方案
Trials. 2020 Jun 11;21(1):516. doi: 10.1186/s13063-020-04390-3.
3
Early surfactant administration with brief ventilation vs. selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome.早期使用表面活性剂并进行短暂通气与选择性使用表面活性剂及持续机械通气用于患有或有呼吸窘迫综合征风险的早产儿的比较。
Cochrane Database Syst Rev. 2007 Oct 17;2007(4):CD003063. doi: 10.1002/14651858.CD003063.pub3.
4
The influence of the technique of surfactant administration (LISA vs INSURE) on the outcomes of respiratory distress syndrome treatment in preterm infants.表面活性剂给药技术(肺内滴注法与气管插管-肺表面活性物质给药法)对早产儿呼吸窘迫综合征治疗结局的影响。
Dev Period Med. 2019;23(3):163-171. doi: 10.34763/devperiodmed.20192303.163171.
5
[Epidemiological survey of neonatal respiratory distress syndrome in part of northwest regions in China].[中国西北地区部分地区新生儿呼吸窘迫综合征的流行病学调查]
Zhonghua Er Ke Za Zhi. 2015 May;53(5):341-7.
6
Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for RDS.对于患有呼吸窘迫综合征(RDS)或有RDS风险的早产儿,早期给予表面活性剂并进行短暂通气与选择性给予表面活性剂及持续机械通气的比较。
Cochrane Database Syst Rev. 2002(2):CD003063. doi: 10.1002/14651858.CD003063.
7
[Mortality risk factors in premature infants with respiratory distress syndrome treated by mechanical ventilation].[机械通气治疗的呼吸窘迫综合征早产儿的死亡风险因素]
Srp Arh Celok Lek. 2005 Jan-Feb;133(1-2):29-35. doi: 10.2298/sarh0502029f.
8
Less Invasive Surfactant Administration in Preterm Infants with Respiratory Distress Syndrome.在患有呼吸窘迫综合征的早产儿中进行的微创表面活性剂给药
J Coll Physicians Surg Pak. 2019 Mar;29(3):226-330. doi: 10.29271/jcpsp.2019.03.226.
9
Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome.早期使用表面活性剂并短暂通气与选择性使用表面活性剂及持续机械通气治疗患有或有呼吸窘迫综合征风险的早产儿的比较
Cochrane Database Syst Rev. 2004(3):CD003063. doi: 10.1002/14651858.CD003063.pub2.
10
Five-year single center experience on surfactant treatment in preterm infants with respiratory distress syndrome: LISA vs INSURE.5 年单中心肺表面活性物质治疗早产儿呼吸窘迫综合征经验:LISA 与 INSURE 比较。
Early Hum Dev. 2019 Aug;135:32-36. doi: 10.1016/j.earlhumdev.2019.06.004. Epub 2019 Jun 20.

引用本文的文献

1
Transforming neonatal nursing: a randomized controlled trial comparing kangaroo care and standard protocols for survival in preterm infants with respiratory distress syndrome.变革新生儿护理:一项比较袋鼠式护理与标准方案对呼吸窘迫综合征早产儿存活率影响的随机对照试验
BMC Nurs. 2025 Apr 16;24(1):430. doi: 10.1186/s12912-025-03088-8.

本文引用的文献

1
Real-world outcomes of niraparib treatment in patients with ovarian cancer: a multicenter non-interventional study in China.尼拉帕利治疗卵巢癌患者的真实世界结局:一项中国多中心非干预性研究
Cancer Commun (Lond). 2023 Jun;43(6):716-719. doi: 10.1002/cac2.12418. Epub 2023 Apr 11.
2
European Consensus Guidelines on the Management of Respiratory Distress Syndrome: 2022 Update.欧洲呼吸窘迫综合征管理共识指南:2022 年更新版。
Neonatology. 2023;120(1):3-23. doi: 10.1159/000528914. Epub 2023 Feb 15.
3
Chinese Neonatal Network: a national protocol for collaborative research and quality improvement in neonatal care.
中国新生儿协作网:新生儿护理协作研究与质量改进的全国性方案。
BMJ Open. 2022 May 2;12(5):e051175. doi: 10.1136/bmjopen-2021-051175.
4
Neonatal Resuscitation Practices in Europe: A Survey of the Union of European Neonatal and Perinatal Societies.欧洲新生儿复苏实践:欧洲新生儿与围产医学会联盟的一项调查
Neonatology. 2022;119(2):184-192. doi: 10.1159/000520617. Epub 2022 Jan 20.
5
Mortality, In-Hospital Morbidity, Care Practices, and 2-Year Outcomes for Extremely Preterm Infants in the US, 2013-2018.美国 2013-2018 年极早产儿的死亡率、住院期间发病率、护理实践和 2 年结局。
JAMA. 2022 Jan 18;327(3):248-263. doi: 10.1001/jama.2021.23580.
6
The social role of pediatrics in the past and present times.儿科学在过去和现在的社会角色。
Ital J Pediatr. 2021 Dec 18;47(1):239. doi: 10.1186/s13052-021-01190-6.
7
FiO Before Surfactant, but Not Time to Surfactant, Affects Outcomes in Infants With Respiratory Distress Syndrome.在使用表面活性剂之前的吸氧浓度(FiO₂),而非使用表面活性剂的时间,会影响呼吸窘迫综合征婴儿的预后。
Front Pediatr. 2021 Oct 4;9:734696. doi: 10.3389/fped.2021.734696. eCollection 2021.
8
Early nasal continuous positive airway pressure failure prediction in preterm infants less than 32 weeks gestational age suffering from respiratory distress syndrome.孕龄小于32周的呼吸窘迫综合征早产儿早期鼻持续气道正压通气失败的预测
Pediatr Pulmonol. 2021 Dec;56(12):3879-3886. doi: 10.1002/ppul.25678. Epub 2021 Oct 5.
9
Assessment of Neonatal Intensive Care Unit Practices, Morbidity, and Mortality Among Very Preterm Infants in China.中国极低出生体重儿新生儿重症监护病房实践、发病和死亡评估。
JAMA Netw Open. 2021 Aug 2;4(8):e2118904. doi: 10.1001/jamanetworkopen.2021.18904.
10
[Consensus for pulmonary surfactant therapy in neonates in China (2021)].中国新生儿肺表面活性物质治疗专家共识(2021年)
Zhonghua Er Ke Za Zhi. 2021 Aug 2;59(8):627-632. doi: 10.3760/cma.j.cn112140-20210329-00261.